Boston Sci nets EU approval for new RFA catheter
Boston Scientific has received CE mark approval in Europe for its Blazer open-irrigated catheter, a radiofrequency ablation (RFA) catheter designed to treat arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.
The Blazer integrates a Total Tip Cooling design with the Blazer catheter platform, the company said. The Total Tip Cooling design is intended to cool the tip electrode during radiofrequency energy delivery through both internal cooling and external washing of the tip electrode, which is designed to reduce coagulum at the proximal edges of the tip.
The first European procedure using the Blazer was performed at the Hopital Cardiologique du Haut-Leveque in Bordeaux-Pessac, France, under the supervision of Michel Haissaguerre, MD.
The product is being launched this quarter in select CE Mark countries, according to the Natick, Mass.-based company.
The Blazer integrates a Total Tip Cooling design with the Blazer catheter platform, the company said. The Total Tip Cooling design is intended to cool the tip electrode during radiofrequency energy delivery through both internal cooling and external washing of the tip electrode, which is designed to reduce coagulum at the proximal edges of the tip.
The first European procedure using the Blazer was performed at the Hopital Cardiologique du Haut-Leveque in Bordeaux-Pessac, France, under the supervision of Michel Haissaguerre, MD.
The product is being launched this quarter in select CE Mark countries, according to the Natick, Mass.-based company.